45
Views
189
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1

, , , &
Pages 3316-3326 | Received 06 Jun 2001, Accepted 19 Feb 2002, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Jonathan A. Cooper, Tomonori Kaneko & Shawn S. C. Li. (2015) Cell Regulation by Phosphotyrosine-Targeted Ubiquitin Ligases. Molecular and Cellular Biology 35:11, pages 1886-1897.
Read now
Serge Y. Fuchs. (2012) Ubiquitination-mediated regulation of interferon responses. Growth Factors 30:3, pages 141-148.
Read now
Stephen T Oh & Jason Gotlib. (2010) JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms. Expert Review of Hematology 3:3, pages 323-337.
Read now
Scott A. Robertson, Rositsa I. Koleva, Lawrence S. Argetsinger, Christin Carter-Su, Jarrod A. Marto, Edward P. Feener & Martin G. Myers$suffix/text()$suffix/text(). (2009) Regulation of Jak2 Function by Phosphorylation of Tyr317 and Tyr637 during Cytokine Signaling. Molecular and Cellular Biology 29:12, pages 3367-3378.
Read now
Lei Nie, S. Scott Perry, Ying Zhao, Jiaxue Huang, Paul W. Kincade, Michael A. Farrar & Xiao-Hong Sun. (2008) Regulation of Lymphocyte Development by Cell-Type-Specific Interpretation of Notch Signals. Molecular and Cellular Biology 28:6, pages 2078-2090.
Read now
Xiao-Tong Song, Melissa Aldrich & Si-Yi Chen. (2006) Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccination. Expert Review of Vaccines 5:4, pages 495-503.
Read now
Jeanette Nilsson, Gunnar Bjursell & Marie Kannius-Janson. (2006) Nuclear Jak2 and Transcription Factor NF1-C2: a Novel Mechanism of Prolactin Signaling in Mammary Epithelial Cells. Molecular and Cellular Biology 26:15, pages 5663-5674.
Read now
Evan Ingley & S. Peter Klinken. (2006) Cross-regulation of JAK and Src kinases. Growth Factors 24:1, pages 89-95.
Read now
Gillian M. Tannahill, Joanne Elliott, Anna C. Barry, Linda Hibbert, Nicolas A. Cacalano & James A. Johnston. (2005) SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation. Molecular and Cellular Biology 25:20, pages 9115-9126.
Read now
Jihong Chen, Jonathan R. St-Germain & Qiao Li. (2005) B56 Regulatory Subunit of Protein Phosphatase 2A Mediates Valproic Acid-Induced p300 Degradation. Molecular and Cellular Biology 25:2, pages 525-532.
Read now
Bao Q. Vuong, Teresita L. Arenzana, Brian M. Showalter, Julie Losman, X. Peter Chen, Justin Mostecki, Alexander S. Banks, Andre Limnander, Neil Fernandez & Paul B. Rothman. (2004) SOCS-1 Localizes to the Microtubule Organizing Complex-Associated 20S Proteasome. Molecular and Cellular Biology 24:20, pages 9092-9101.
Read now

Articles from other publishers (178)

Hui-Jun Cao, Hao Jiang, Kai Ding, Xiao-Song Qiu, Ning Ma, Feng-Kun Zhang, Yi-Kang Wang, Qian-Wen Zheng, Ji Xia, Qian-Zhi Ni, Sheng Xu, Bing Zhu, Xu-Fen Ding, Tian-Wei Chen, Lin Qiu, Wei Chen, Zhi-Gang Li, Bin Zhou, Wen-Ming Feng, Dong Xie & Jing-Jing Li. (2022) ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2. Cell Death & Differentiation 30:2, pages 383-396.
Crossref
Monireh Rezaei, Zinat Shams, Bahareh Sadat Rasouli, Katayoun Dadeh Amirfard, Mohadeseh Soleymani Sadrabadi, Ali Gheysarzadeh, Karimeh Haghani & Salar Bakhtiyari. (2023) New Association Between Diabetes Mellitus and Pancreatic Cancer. Current Diabetes Reviews 19:1.
Crossref
Rebeccah A. Warmack, Eric Z. Pang, Esther Peluso, Jonathan D. Lowenson, Joseph Y. Ong, Jorge Z. Torres & Steven G. Clarke. (2022) Human Protein- l -isoaspartate O -Methyltransferase Domain-Containing Protein 1 (PCMTD1) Associates with Cullin-RING Ligase Proteins . Biochemistry 61:10, pages 879-894.
Crossref
Jing Yang, Ellen L. Weisberg, Xiaoxi Liu, Robert S. Magin, Wai Cheung Chan, Bin Hu, Nathan J. Schauer, Shengzhe Zhang, Ilaria Lamberto, Laura Doherty, Chengcheng Meng, Martin Sattler, Lucia Cabal-Hierro, Eric Winer, Richard Stone, Jarrod A. Marto, James D. Griffin & Sara J. Buhrlage. (2021) Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2. Leukemia 36:1, pages 210-220.
Crossref
Mirva Järvelä-Stölting, Laura Vesala, Matthew K. Maasdorp, Joanna Ciantar, Mika Rämet & Susanna Valanne. (2021) Proteasome α6 Subunit Negatively Regulates the JAK/STAT Pathway and Blood Cell Activation in Drosophila melanogaster. Frontiers in Immunology 12.
Crossref
Qianqian Yin, Longyun Wang, Haiyang Yu, Daquan Chen, Wenwei Zhu & Changgang Sun. (2021) Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway. Frontiers in Pharmacology 12.
Crossref
Hyun-Soo Park, Joo-Hui Han, Jeong Won Park, Do-Hyung Lee, Keun-Woo Jang, Miji Lee, Kyung-Sun Heo & Chang-Seon Myung. (2020) Sodium propionate exerts anticancer effect in mice bearing breast cancer cell xenograft by regulating JAK2/STAT3/ROS/p38 MAPK signaling. Acta Pharmacologica Sinica 42:8, pages 1311-1323.
Crossref
Masahiro Yasuda, Sivapratha Nagappan-Chettiar, Erin M. Johnson-Venkatesh & Hisashi Umemori. (2021) An activity-dependent determinant of synapse elimination in the mammalian brain. Neuron 109:8, pages 1333-1349.e6.
Crossref
Nicola Padzik & Małgorzata Szewczuk. (2021) Molecular basis of essential thrombocythaemia in humans and dogs – a review. Roczniki Naukowe Polskiego Towarzystwa Zootechnicznego 17:1, pages 13-21.
Crossref
Valentina Budroni & Gijs A. Versteeg. (2021) Negative Regulation of the Innate Immune Response through Proteasomal Degradation and Deubiquitination. Viruses 13:4, pages 584.
Crossref
Yash Chhabra, Christine M.M. Lee, Alexandra Franziska Müller & Andrew J. Brooks. (2021) GHR signalling: Receptor activation and degradation mechanisms. Molecular and Cellular Endocrinology 520, pages 111075.
Crossref
Salma Merchant. 2021. Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A. Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A 117 162 .
Yongchao Zhao, Xiufang Xiong & Yi Sun. (2020) Cullin-RING Ligase 5: Functional characterization and its role in human cancers. Seminars in Cancer Biology 67, pages 61-79.
Crossref
Ger J. Strous, Ana Da Silva Almeida, Joyce Putters, Julia Schantl, Magdalena Sedek, Johan A. Slotman, Tobias Nespital, Gerco C. Hassink & Jan A. Mol. (2020) Growth Hormone Receptor Regulation in Cancer and Chronic Diseases. Frontiers in Endocrinology 11.
Crossref
Mengmeng Zhao, Asuka Nanbo, David Becnel, Zhiqiang Qin, Gilbert F. Morris, Li Li & Zhen Lin. (2020) Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta. Journal of Virology 94:22.
Crossref
Amalia Lamana, Ricardo Villares, Iria V. Seoane, Nuria Andrés, Pilar Lucas, Paul Emery, Edward M. Vital, Ana Triguero-Martínez, Ana Marquez, Ana M. Ortiz, Robin Maxime, Carmen Martínez, Javier Martín, Rosa P. Gomariz, Frederique Ponchel, Isidoro González-Álvaro & Mario Mellado. (2020) Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity. Frontiers in Immunology 11.
Crossref
Albert Kolomansky, Sahar Hiram-Bab, Nathalie Ben-Califa, Tamar Liron, Naamit Deshet-Unger, Moshe Mittelman, Howard Oster, Martina Rauner, Ben Wielockx, Drorit Neumann & Yankel Gabet. (2020) Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible. International Journal of Molecular Sciences 21:11, pages 3817.
Crossref
Hiroshi Kanno, Tetsuya Yoshizumi, Masamichi Shinonaga, Atsuhiko Kubo, Hidetoshi Murata & Masahiro Yao. (2020) Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease. Journal of Neuro-Oncology 148:1, pages 29-38.
Crossref
Andre Villanueva, Kok Siong Poon, Christian Aledia Gallardo, Chean Nee Chai, Lily Chiu, Benedict Yan, Cristine S. L. Ding, Kol Jia Yong, Jianbiao Zhou, Joanne Lee, Karen Tan & Kiat Hoe Ong. (2019) A novel JAK2 R564* variant in a patient with thrombocytosis. International Journal of Laboratory Hematology 42:2.
Crossref
Rishi R. Shah, Joanna M. Redmond, Andrei Mihut, Malini Menon, John P. Evans, John A. Murphy, Michelle A. Bartholomew & Diane M. Coe. (2020) Hi-JAK-ing the ubiquitin system: The design and physicochemical optimisation of JAK PROTACs. Bioorganic & Medicinal Chemistry 28:5, pages 115326.
Crossref
Andrea Price, Lawrence J. Druhan, Amanda Lance, Gavin Clark, C. Greer Vestal, Qing Zhang, David Foureau, Judy Parsons, Alicia Hamilton, Nury M. Steuerwald & Belinda R. Avalos. (2020) T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form. Biochemical and Biophysical Research Communications 523:1, pages 208-213.
Crossref
Shizhen Zhang & Yi Sun. 2020. Cullin-RING Ligases and Protein Neddylation. Cullin-RING Ligases and Protein Neddylation 261 283 .
M. C. P. Cleophas, T. O. Crişan, V. Klück, N. Hoogerbrugge, R. T. Netea-Maier, C. A. Dinarello, M. G. Netea & L. A. B. Joosten. (2019) Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression. Arthritis Research & Therapy 21:1.
Crossref
Terrence M. DonohueJr.Jr., Natalia A. Osna, Kusum K. Kharbanda & Paul G. Thomes. (2019) Lysosome and proteasome dysfunction in alcohol-induced liver injury. Liver Research 3:3-4, pages 191-205.
Crossref
Sytse J. Piersma, Melissa A. Pak-Wittel, Andrea Lin, Beatrice Plougastel-Douglas & Wayne M. Yokoyama. (2019) Activation Receptor–Dependent IFN-γ Production by NK Cells Is Controlled by Transcription, Translation, and the Proteasome. The Journal of Immunology 203:7, pages 1981-1988.
Crossref
Dagmar Hildebrand, Camila Metz-Zumaran, Greta Jaschkowitz & Klaus Heeg. (2019) Silencing SOCS1 via Liposome-Packed siRNA Sustains TLR4-Ligand Adjuvant. Frontiers in Immunology 10.
Crossref
Ryan Donaghy, Xu Han, Krasimira Rozenova, Kaosheng Lv, Qinqin Jiang, Miriam Doepner, Roger A. Greenberg & Wei Tong. (2019) The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination. Blood 133:14, pages 1560-1571.
Crossref
Chia-Huei Lee, Ji-Rui Yang, Chih-Yu Chen, Ming-Hsien Tsai, Pin-Feng Hung, Shin-Jih Chen, Shang-Lun Chiang, Han Chang & Pinpin Lin. (2019) Novel STAT3 Inhibitor LDOC1 Targets Phospho-JAK2 for Degradation by Interacting with LNX1 and Regulates the Aggressiveness of Lung Cancer. Cancers 11:1, pages 63.
Crossref
Pei-Li Zhu, Xiu-Qiong Fu, Jun-Kui Li, Anfernee Kai-Wing Tse, Hui Guo, Cheng-Le Yin, Ji-Yao Chou, Ya-Ping Wang, Yu-Xi Liu, Ying-Jie Chen, Muhammad Jahangir Hossen, Yi Zhang, Si-Yuan Pan, Zong-Jie Zhao & Zhi-Ling Yu. (2018) Antrodia camphorata Mycelia Exert Anti-liver Cancer Effects and Inhibit STAT3 Signaling in vitro and in vivo. Frontiers in Pharmacology 9.
Crossref
Marta Kot & Martine Daujat-Chavanieu. (2018) Altered cytokine profile under control of the serotonergic system determines the regulation of CYP2C11 and CYP3A isoforms. Food and Chemical Toxicology 116, pages 369-378.
Crossref
Hiroshi Kanno, Yuqun Xu, Taykua Miyakawa, Atsuhiko Kubo, Tetsuhiro Higashida, Nahoko Kobayashi, Tetsuhiko Yoshida & Masaru Tanokura. (2018) BC-Box Motif-Mediated Neuronal Differentiation of Somatic Stem Cells. International Journal of Molecular Sciences 19:2, pages 466.
Crossref
Adeola A. Obajemu, Nina Rao, Kari A. Dilley, Joselin M. Vargas, Faruk Sheikh, Raymond P. Donnelly, Reed S. Shabman, Eric G. Meissner, Ludmila Prokunina-Olsson & Olusegun O. Onabajo. (2017) IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling. The Journal of Immunology 199:11, pages 3808-3820.
Crossref
Farhad Seif, Majid Khoshmirsafa, Hossein Aazami, Monireh Mohsenzadegan, Gholamreza Sedighi & Mohammadali Bahar. (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Communication and Signaling 15:1.
Crossref
Chun-Shan Liu, Hsin-Fang Yang-Yen, Ching-Shu Suen, Ming-Jing Hwang & Jeffrey Jong-Young Yen. (2017) Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction. Scientific Reports 7:1.
Crossref
Kaosheng Lv, Jing Jiang, Ryan Donaghy, Christopher R. Riling, Ying Cheng, Vemika Chandra, Krasimira Rozenova, Wei An, Bhopal C. Mohapatra, Benjamin T. Goetz, Vinodh Pillai, Xu Han, Emily A. Todd, Grace R. Jeschke, Wallace Y. Langdon, Suresh Kumar, Elizabeth O. Hexner, Hamid Band & Wei Tong. (2017) CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies. Genes & Development 31:10, pages 1007-1023.
Crossref
Lixin Wan, Ming Chen, Juxiang Cao, Xiangpeng Dai, Qing Yin, Jinfang Zhang, Su-Jung Song, Ying Lu, Jing Liu, Hiroyuki Inuzuka, Jesse M. Katon, Kelsey Berry, Jacqueline Fung, Christopher Ng, Pengda Liu, Min Sup Song, Lian Xue, Roderick T. Bronson, Marc W. Kirschner, Rutao Cui, Pier Paolo Pandolfi & Wenyi Wei. (2017) The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function. Cancer Discovery 7:4, pages 424-441.
Crossref
Masahiro Maruoka, Shin Kedashiro, Yuki Ueda, Kiyohito Mizutani & Yoshimi Takai. (2017) Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway. Journal of Biological Chemistry 292:17, pages 6895-6909.
Crossref
Caitlyn Vlasschaert, David Cook, Xuhua Xia & Douglas A. Gray. (2017) The Evolution and Functional Diversification of the Deubiquitinating Enzyme Superfamily. Genome Biology and Evolution 9:3, pages 558-573.
Crossref
Seiji Tsunematsu, Goki Suda, Kazushi Yamasaki, Megumi Kimura, Takaaki Izumi, Machiko Umemura, Jun Ito, Fumiyuki Sato, Masato Nakai, Takuya Sho, Kenichi Morikawa, Koji Ogawa, Yasuhito Tanaka, Koichi Watashi, Takaji Wakita & Naoya Sakamoto. (2017) Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A. Journal of Medical Virology 89:2, pages 267-275.
Crossref
R. Berzaghi, V. S. C. Maia, F. V. Pereira, F. M. Melo, M. S. Guedes, C. S. T. Origassa, J. B. Scutti, A. L. Matsuo, N. O. S. Câmara, E. G. Rodrigues & L. R. Travassos. (2017) SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression. Scientific Reports 7:1.
Crossref
Xingxing Zhang, Jian Wu, Bo Ye, Qiong Wang, Xiaodong Xie & Hong Shen. (2016) Protective effect of curcumin on TNBS-induced intestinal inflammation is mediated through the JAK/STAT pathway. BMC Complementary and Alternative Medicine 16:1.
Crossref
Ana Textor, Karin Schmidt, Peter-M. Kloetzel, Bianca Weißbrich, Cynthia Perez, Jehad Charo, Kathleen Anders, John Sidney, Alessandro Sette, Ton N.M. Schumacher, Christin Keller, Dirk H. Busch, Ulrike Seifert & Thomas Blankenstein. (2016) Preventing tumor escape by targeting a post-proteasomal trimming independent epitope. Journal of Experimental Medicine 213:11, pages 2333-2348.
Crossref
Claire E. O’Leary, Christopher R. Riling, Lynn A. Spruce, Hua Ding, Suresh Kumar, Guoping Deng, Yuhong Liu, Steven H. Seeholzer & Paula M. Oliver. (2016) Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nature Communications 7:1.
Crossref
Isabelle Lamsoul, Sandrine Uttenweiler-Joseph, Christel Moog-Lutz & Pierre G. Lutz. (2016) Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?. Biochimie 122, pages 339-347.
Crossref
Markus BenderSilvia GianniniRenata GrozovskyTerese JönssonHilary Christensen, Fred G. Pluthero, Amy KoAnn MullallyWalter H. A. Kahr, Karin M. HoffmeisterHervé Falet. (2015) Dynamin 2–dependent endocytosis is required for normal megakaryocyte development in mice. Blood 125:6, pages 1014-1024.
Crossref
VINAYAK KHATTAR & JAIDEEP V. THOTTASSERY. (2015) Cks1 proteasomal turnover is a predominant mode of regulation in breast cancer cells: Role of key tyrosines and lysines. International Journal of Oncology 46:1, pages 395-406.
Crossref
Ahmed E. Goda, Raymond L. Erikson, Toshiyuki Sakai, Jong-Seog Ahn & Bo-Yeon Kim. (2015) Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies. Molecular Oncology 9:1, pages 309-322.
Crossref
Sayaka Sukegawa, Ryuta Sakuma, Seiga Ohmine, Hiroaki Takeuchi, Yasuhiro Ikeda & Shoji Yamaoka. (2014) Suppressor of Cytokine Signaling 1 Counteracts Rhesus Macaque TRIM5α-Induced Inhibition of Human Immunodeficiency Virus Type-1 Production. PLoS ONE 9:10, pages e109640.
Crossref
Dong Soon Choi, Elvin Blanco, Yoo-Shin Kim, Angel A. Rodriguez, Hong Zhao, Tim Hui-Ming Huang, Chun-Liang Chen, Guangxu Jin, Melissa D. Landis, Lacey A. Burey, Wei Qian, Sergio M. Granados, Bhuvanesh Dave, Helen H. Wong, Mauro Ferrari, Stephen T. C. Wong & Jenny C. Chang. (2014) Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1. Stem Cells 32:9, pages 2309-2323.
Crossref
Jamie Williams, Kirsten Munro & Timothy Palmer. (2014) Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression. Cells 3:2, pages 546-562.
Crossref
Sylvia Müller, Yuan Chen, Torsten Ginter, Claudia Schäfer, Marc Buchwald, Lienhard M. Schmitz, Jana Klitzsch, Alexander Schütz, Andrea Haitel, Katharina Schmid, Richard Moriggl, Lukas Kenner, Karlheinz Friedrich, Claude Haan, Iver Petersen, Thorsten Heinzel & Oliver H. Krämer. (2014) SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells. Oncotarget 5:10, pages 3184-3196.
Crossref
Walid Sasi, Anup K. Sharma & Kefah Mokbel. (2014) The Role of Suppressors of Cytokine Signalling in Human Neoplasms. Molecular Biology International 2014, pages 1-24.
Crossref
J L Metcalf, P S Bradshaw, M Komosa, S N Greer, M Stephen Meyn & M Ohh. (2013) K63-Ubiquitylation of VHL by SOCS1 mediates DNA double-strand break repair. Oncogene 33:8, pages 1055-1065.
Crossref
M G Mathieu, A K Miles, M Ahmad, M E Buczek, A G Pockley, R C Rees & T Regad. (2014) The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death & Disease 5:2, pages e1061-e1061.
Crossref
Eric KeilDavid FinkenstädtChristian WufkaMirko Trilling, Pia LiebfriedBirgit Strobl, Mathias Müller & Klaus Pfeffer. (2014) Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation-loop mutation. Blood 123:4, pages 520-529.
Crossref
Haitao Wei, Song Wang, Qinghuang Chen, Yuhai Chen, Xiaojuan Chi, Lianfeng Zhang, Shile Huang, George F. Gao & Ji-Long Chen. (2014) Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection. PLoS Pathogens 10:1, pages e1003845.
Crossref
Christina Aaen Andresen, Stine Smedegaard, Kathrine Beck Sylvestersen, Charlotte Svensson, Diego Iglesias-Gato, Giuseppe Cazzamali, Tine Kragh Nielsen, Michael Lund Nielsen & Amilcar Flores-Morales. (2014) Protein Interaction Screening for the Ankyrin Repeats and Suppressor of Cytokine Signaling (SOCS) Box (ASB) Family Identify Asb11 as a Novel Endoplasmic Reticulum Resident Ubiquitin Ligase. Journal of Biological Chemistry 289:4, pages 2043-2054.
Crossref
Min Ho Kim, Young-Jin Son, Sang Yeol Lee, Woo Seok Yang, Young-Su Yi, Deok Hyo Yoon, Yanyan Yang, Shi Hyoung Kim, Duckhee Lee, Man Hee Rhee, Hyojeung Kang, Tae Woong Kim, Gi-Ho Sung & Jae Youl Cho. (2013) JAK2-targeted anti-inflammatory effect of a resveratrol derivative 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide. Biochemical Pharmacology 86:12, pages 1747-1761.
Crossref
Severa Bunda, Kamya Kommaraju, Pardeep Heir & Michael Ohh. (2013) SOCS-1 Mediates Ubiquitylation and Degradation of GM-CSF Receptor. PLoS ONE 8:9, pages e76370.
Crossref
Maiara S. Severo, Olivia S. Sakhon, Anthony Choy, Kimberly D. Stephens & Joao H. F. Pedra. (2013) The ‘ubiquitous’ reality of vector immunology. Cellular Microbiology 15:7, pages 1070-1078.
Crossref
Chi-qi Chen, Kang Yu, Qing-xian Yan, Chong-yun Xing, Yi Chen, Zhuang Yan, Yi-fen Shi, Ke-Wen Zhao & Shen-meng Gao. (2013) Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class Ι histone deacetylases. Carcinogenesis 34:7, pages 1442-1449.
Crossref
Timothy R. Hercus, Urmi Dhagat, Winnie L.T. Kan, Sophie E. Broughton, Tracy L. Nero, Michelle Perugini, Jarrod J. Sandow, Richard J. D’Andrea, Paul G. Ekert, Timothy Hughes, Michael W. Parker & Angel F. Lopez. (2013) Signalling by the βc family of cytokines. Cytokine & Growth Factor Reviews 24:3, pages 189-201.
Crossref
Shen-meng Gao, Chi-qi Chen, Lu-yao Wang, Li-li Hong, Jian-bo Wu, Pei-hong Dong & Fu-jun Yu. (2013) Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms. Experimental Hematology 41:3, pages 261-270.e4.
Crossref
Verónica Parrillas, Laura Martínez-Muñoz, Borja L. Holgado, Amit Kumar, Graciela Cascio, Pilar Lucas, José Miguel Rodríguez-Frade, Marcos Malumbres, Ana C. Carrera, Karel HM van Wely & Mario Mellado. (2012) Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells. Cellular and Molecular Life Sciences 70:3, pages 545-558.
Crossref
Natalia A. Osna & Terrence M. DonohueJr.Jr.. 2013. Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism. Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism 177 197 .
Tobias Nespital & Ger J. Strous. (2012) The Jak/Stat Signaling Pathway Is Downregulated at Febrile Temperatures. PLoS ONE 7:11, pages e49374.
Crossref
Bingqian Qu, Xian Qi, Xiaodong Wu, Mifang Liang, Chuan Li, Carol J. Cardona, Wayne Xu, Fenyang Tang, Zhifeng Li, Bing Wu, Kira Powell, Marta Wegner, Dexin Li & Zheng Xing. (2012) Suppression of the Interferon and NF-κB Responses by Severe Fever with Thrombocytopenia Syndrome Virus. Journal of Virology 86:16, pages 8388-8401.
Crossref
Xiaoxue Qiu, Guijie Guo, Ke Chen, Masaki Kashiwada, Brian J. Druker, Paul B. Rothman & Ji-Long Chen. (2012) A Requirement for SOCS-1 and SOCS-3 Phosphorylation in Bcr-Abl-Induced Tumorigenesis. Neoplasia 14:6, pages 547-IN22.
Crossref
Evan Ingley. (2012) Integrating novel signaling pathways involved in erythropoiesis. IUBMB Life 64:5, pages 402-410.
Crossref
Nunzianna Doti, Pasqualina L. Scognamiglio, Stefania Madonna, Claudia Scarponi, Menotti Ruvo, Giuseppe Perretta, Cristina Albanesi & Daniela Marasco. (2012) New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries. Biochemical Journal 443:1, pages 231-240.
Crossref
Edmond M. Linossi & Sandra E. Nicholson. (2012) The SOCS box-Adapting proteins for ubiquitination and proteasomal degradation. IUBMB Life 64:4, pages 316-323.
Crossref
Claude Haan, Daniela Ungureanu, Tuija Pekkala, Olli Silvennoinen & Serge Haan. 2012. Jak-Stat Signaling : From Basics to Disease. Jak-Stat Signaling : From Basics to Disease 5 25 .
Wei Wu & Xiao-Hong Sun. (2011) A Mechanism Underlying NOTCH-Induced and Ubiquitin-mediated JAK3 Degradation. Journal of Biological Chemistry 286:48, pages 41153-41162.
Crossref
Vaibhav Kapuria, Alexander Levitzki, William G. Bornmann, David Maxwell, Waldemar Priebe, Roderick J. Sorenson, Hollis D. Showalter, Moshe Talpaz & Nicholas J. Donato. (2011) A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination. Cellular Signalling 23:12, pages 2076-2085.
Crossref
Jonathan T. Lei, Tuhina Mazumdar & Margarita Martinez-Moczygemba. (2011) Three Lysine Residues in the Common β Chain of the Interleukin-5 Receptor Are Required for Janus Kinase (JAK)-dependent Receptor Ubiquitination, Endocytosis, and Signaling. Journal of Biological Chemistry 286:46, pages 40091-40103.
Crossref
Natalina E. ElliottSusan M. ClevelandVictor GrannJohn Janik, Thomas A. Waldmann & Utpal P. Davé. (2011) FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma. Blood 118:14, pages 3911-3921.
Crossref
Justin Mostecki, Suzanne L. Cassel, Walter T. Klimecki, Debra A. Stern, Judit Knisz, Sachiyo Iwashita, Penelope Graves, Rachel L. Miller, Maartje van Peer, Marilyn Halonen, Fernando D. Martinez, Donata Vercelli & Paul B. Rothman. (2011) A SOCS-1 Promoter Variant Is Associated with Total Serum IgE Levels. The Journal of Immunology 187:5, pages 2794-2802.
Crossref
Ryan C Russell, Roxana I Sufan, Bing Zhou, Pardeep Heir, Severa Bunda, Stephanie S Sybingco, Samantha N Greer, Olga Roche, Samuel A Heathcote, Vinca W K Chow, Lukasz M Boba, Terri D Richmond, Michele M Hickey, Dwayne L Barber, David A Cheresh, M Celeste Simon, Meredith S Irwin, William Y Kim & Michael Ohh. (2011) Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia. Nature Medicine 17:7, pages 845-853.
Crossref
Sandip Bhattacharyya, Yuxing Zhao, Thomas W. H. Kay & Louis J. Muglia. (2011) Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor–induced STAT1 activation. Proceedings of the National Academy of Sciences 108:23, pages 9554-9559.
Crossref
Lei Nie, Ying Zhao, Wei Wu, Yuan-Zheng Yang, Hong-Cheng Wang & Xiao-Hong Sun. (2010) Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes. Cell Research 21:5, pages 754-769.
Crossref
Tadashi Nishiya, Kazuma Matsumoto, Satoshi Maekawa, Emi Kajita, Takahiro Horinouchi, Masahiro Fujimuro, Kouetsu Ogasawara, Takashi Uehara & Soichi Miwa. (2011) Regulation of Inducible Nitric-oxide Synthase by the SPRY Domain- and SOCS Box-containing Proteins. Journal of Biological Chemistry 286:11, pages 9009-9019.
Crossref
Fabio P.S. Santos & Srdan Verstovsek. (2011) JAK2 inhibitors: What's the true therapeutic potential?. Blood Reviews 25:2, pages 53-63.
Crossref
Rebecca A. Helmer, Marlyn Panchoo, Janet S. Dertien, Suhani M. Bhakta, Aveline Hewetson & Beverly S. Chilton. (2010) Prolactin-induced Jak2 phosphorylation of RUSH: A key element in Jak/RUSH signaling. Molecular and Cellular Endocrinology 325:1-2, pages 143-149.
Crossref
Maria T. PallottaCiriana OrabonaClaudia VolpiUrsula GrohmannPaolo PuccettiFrancesca Fallarino. (2010) Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 + Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3) . International Journal of Tryptophan Research 3, pages IJTR.S3971.
Crossref
Benjamin G. Neel, Gordon Chan & Salim Dhanji. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling 771 809 .
James M. Murphy, Gillian M. Tannahill, Douglas J. Hilton & Christopher J. Greenhalgh. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling 467 480 .
Claire Rutherford & Timothy M. Palmer. 2010. Systems Biology for Signaling Networks. Systems Biology for Signaling Networks 561 587 .
S Haan, S Wüller, J Kaczor, C Rolvering, T Nöcker, I Behrmann & C Haan. (2009) SOCS-mediated downregulation of mutant Jak2 (V617F, T875N and K539L) counteracts cytokine-independent signaling. Oncogene 28:34, pages 3069-3080.
Crossref
Elena Razumovskaya, Kristina Masson, Rasheed Khan, Susanne Bengtsson & Lars Rönnstrand. (2009) Oncogenic Flt3 receptors display different specificity and kinetics of autophosphorylation. Experimental Hematology 37:8, pages 979-989.
Crossref
Martine Letourneur, Lyne Valentino, Julia Travagli-Gross, Jacques Bertoglio & Josiane Pierre. (2009) Sp2 regulates interferon-γ-mediated socs1 gene expression. Molecular Immunology 46:11-12, pages 2151-2160.
Crossref
Dipak Barua, James R. Faeder & Jason M. Haugh. (2009) A Bipolar Clamp Mechanism for Activation of Jak-Family Protein Tyrosine Kinases. PLoS Computational Biology 5:4, pages e1000364.
Crossref
Kristy Boyle, Jian-Guo Zhang, Sandra E. Nicholson, Evelyn Trounson, Jeffery J. Babon, Edward J. McManus, Nicos A. Nicola & Lorraine Robb. (2009) Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cellular Signalling 21:3, pages 394-404.
Crossref
Suzanne L. Cassel & Paul B. Rothman. 2009. 49 76 .
Harvey F. Lodish, Saghi Ghaffari, Merav Socolovsky, Wei Tong & Jing Zhang. 2009. Erythropoietins, Erythropoietic Factors, and Erythropoiesis. Erythropoietins, Erythropoietic Factors, and Erythropoiesis 155 174 .
Samir Ali & George Kukolj. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance 531 545 .
Ciriana Orabona, Maria T. Pallotta, Claudia Volpi, Francesca Fallarino, Carmine Vacca, Roberta Bianchi, Maria L. Belladonna, Maria C. Fioretti, Ursula Grohmann & Paolo Puccetti. (2008) SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis. Proceedings of the National Academy of Sciences 105:52, pages 20828-20833.
Crossref
Lin Jiang, Zhiqin Li & Liangyou Rui. (2008) Leptin Stimulates Both JAK2-dependent and JAK2-independent Signaling Pathways. Journal of Biological Chemistry 283:42, pages 28066-28073.
Crossref
Julie Piessevaux, Delphine Lavens, Frank Peelman & Jan Tavernier. (2008) The many faces of the SOCS box. Cytokine & Growth Factor Reviews 19:5-6, pages 371-381.
Crossref
Stefania Madonna, Claudia Scarponi, Ornella De Pità & Cristina Albanesi. (2008) Suppressor of cytokine signaling 1 inhibits IFN‐γ inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation. The FASEB Journal 22:9, pages 3287-3297.
Crossref
Caleph B. Wilson, Manujendra Ray, Michael Lutz, Daniel Sharda, Jie Xu & Pamela A. Hankey. (2008) The RON Receptor Tyrosine Kinase Regulates IFN-γ Production and Responses in Innate Immunity. The Journal of Immunology 181:4, pages 2303-2310.
Crossref
Joanne ElliottMichelle B. HookhamJames A. Johnston. (2008) The suppressors of cytokine signalling E3 ligases behave as tumour suppressors. Biochemical Society Transactions 36:3, pages 464-468.
Crossref
Mélina L. Heuzé, Isabelle Lamsoul, Christel Moog-Lutz & Pierre G. Lutz. (2008) Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis. Blood Cells, Molecules, and Diseases 40:2, pages 200-210.
Crossref
Youngkyun LeeSeok-Won Hyung, Hee Jung Jung, Hyung-Joon KimJudith Staerk, Stefan N. Constantinescu, Eun-Ju ChangZang Hee LeeSang-Won Lee & Hong-Hee Kim. (2008) The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-β–induced inhibitory signaling. Blood 111:2, pages 885-893.
Crossref
Karen L. Wu, Hui Miao & Shenaz Khan. (2007) JAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism. American Journal of Physiology-Renal Physiology 293:6, pages F1836-F1846.
Crossref
Vivien M. Hodges, Susan Rainey, Terence R. Lappin & A. Peter Maxwell. (2007) Pathophysiology of anemia and erythrocytosis. Critical Reviews in Oncology/Hematology 64:2, pages 139-158.
Crossref
S J Baker, S G Rane & E P Reddy. (2007) Hematopoietic cytokine receptor signaling. Oncogene 26:47, pages 6724-6737.
Crossref
Kristy BoylePaul EganSteven Rakar, Tracy A. WillsonIan P. WicksDonald MetcalfDouglas J. HiltonNicos A. NicolaWarren S. AlexanderAndrew W. RobertsLorraine Robb. (2007) The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood 110:5, pages 1466-1474.
Crossref
Jayaveeramuthu Nirmala, Stephanie Dahl, Brian J. Steffenson, C. Gamini Kannangara, Diter von Wettstein, Xianming Chen & Andris Kleinhofs. (2007) Proteolysis of the barley receptor-like protein kinase RPG1 by a proteasome pathway is correlated with Rpg1 -mediated stem rust resistance . Proceedings of the National Academy of Sciences 104:24, pages 10276-10281.
Crossref
Michelle B. HookhamJoanne ElliottYvonne SuessmuthJudith StaerkAlister C. WardWilliam Vainchenker, Melanie J. Percy, Mary Frances McMullin, Stefan N. ConstantinescuJames A. Johnston. (2007) The myeloproliferative disorder–associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood 109:11, pages 4924-4929.
Crossref
E Jost, N do Ó, E Dahl, C E Maintz, P Jousten, L Habets, S Wilop, J G Herman, R Osieka & O Galm. (2007) Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders. Leukemia 21:3, pages 505-510.
Crossref
Decheng Ren, Yingjiang Zhou, David Morris, Minghua Li, Zhiqin Li & Liangyou Rui. (2007) Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. Journal of Clinical Investigation 117:2, pages 397-406.
Crossref
Samer Aboudola, Guruanthan Murugesan, Hadrian Szpurka, Giri Ramsingh, Xiaoxian Zhao, Nichole Prescott, Raymond R. Tubbs, Jaroslaw P. Maciejewski & Eric D. Hsi. (2007) Bone Marrow Phospho-STAT5 Expression in Non-CML Chronic Myeloproliferative Disorders Correlates With JAK2 V617F Mutation and Provides Evidence of In Vivo JAK2 Activation. The American Journal of Surgical Pathology 31:2, pages 233-239.
Crossref
Marlyse A. Debrincat, Jian-Guo Zhang, Tracy A. Willson, John Silke, Lisa M. Connolly, Richard J. Simpson, Warren S. Alexander, Nicos A. Nicola, Benjamin T. Kile & Douglas J. Hilton. (2007) Ankyrin Repeat and Suppressors of Cytokine Signaling Box Protein Asb-9 Targets Creatine Kinase B for Degradation. Journal of Biological Chemistry 282:7, pages 4728-4737.
Crossref
Gabriel N Maine, Xicheng Mao, Christine M Komarck & Ezra Burstein. (2006) COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase. The EMBO Journal 26:2, pages 436-447.
Crossref
Kunwar Shailubhai. (2007) Atiprimod: A multi-functional drug candidate for myeloid and other malignancies. Leukemia Research 31:1, pages 9-10.
Crossref
Holger BartzNicole M. AvalosAndrea BaetzKlaus HeegAlexander H. Dalpke. (2006) Involvement of suppressors of cytokine signaling in toll-like receptor–mediated block of dendritic cell differentiation. Blood 108:13, pages 4102-4108.
Crossref
Yuehai Ke, Jacqueline Lesperance, Eric E. Zhang, Emilie A. Bard-Chapeau, Robert G. Oshima, William J. Muller & Gen-Sheng Feng. (2006) Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 Activation. Journal of Biological Chemistry 281:45, pages 34374-34380.
Crossref
Julie Piessevaux, Delphine Lavens, Tony Montoye, Joris Wauman, Dominiek Catteeuw, Joël Vandekerckhove, Denise Belsham, Frank Peelman & Jan Tavernier. (2006) Functional Cross-modulation between SOCS Proteins Can Stimulate Cytokine Signaling. Journal of Biological Chemistry 281:44, pages 32953-32966.
Crossref
J A F Marteijn, J H Jansen & B A van der Reijden. (2006) Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets. Leukemia 20:9, pages 1511-1518.
Crossref
Carlos Leon, Devki Nandan, Martin Lopez, Alireza Moeenrezakhanlou & Neil E. Reiner. (2006) Annexin V Associates with the IFN-γ Receptor and Regulates IFN-γ Signaling. The Journal of Immunology 176:10, pages 5934-5942.
Crossref
Julie Bayle, Sophie Lopez, Kazuhiro Iwaï, Patrice Dubreuil & Paulo De Sepulveda. (2006) The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins. FEBS Letters 580:11, pages 2609-2614.
Crossref
Olivier Staub & Daniela Rotin. (2006) Role of Ubiquitylation in Cellular Membrane Transport. Physiological Reviews 86:2, pages 669-707.
Crossref
Yun He, Wei Zhang, Rong Zhang, Haifeng Zhang & Wang Min. (2006) SOCS1 Inhibits Tumor Necrosis Factor-induced Activation of ASK1-JNK Inflammatory Signaling by Mediating ASK1 Degradation. Journal of Biological Chemistry 281:9, pages 5559-5566.
Crossref
Claudia Stross, Simone Radtke, Thomas Clahsen, Christa Gerlach, Rudolf Volkmer-Engert, Fred Schaper, Peter C. Heinrich & Heike M. Hermanns. (2006) Oncostatin M Receptor-mediated Signal Transduction Is Negatively Regulated by SOCS3 through a Receptor Tyrosine-independent Mechanism. Journal of Biological Chemistry 281:13, pages 8458-8468.
Crossref
Lyne Valentino & Josiane Pierre. (2006) JAK/STAT signal transduction: Regulators and implication in hematological malignancies. Biochemical Pharmacology 71:6, pages 713-721.
Crossref
Amilcar Flores-MoralesChristopher J. Greenhalgh, Gunnar NorstedtElizabeth Rico-Bautista. (2006) Negative Regulation of Growth Hormone Receptor Signaling. Molecular Endocrinology 20:2, pages 241-253.
Crossref
B. Emery, H. Butzkueven, C. Snell, M. Binder & T.J. Kilpatrick. (2006) Oligodendrocytes exhibit selective expression of suppressor of cytokine signaling genes and signal transducer and activator of transcription 1 independent inhibition of interferon-gamma-induced toxicity in response to leukemia inhibitory factor. Neuroscience 137:2, pages 463-472.
Crossref
S.Jaharul Haque & Pankaj Sharma. 2006. Interleukins. Interleukins 165 206 .
Junya Kohroki, Takehiro Nishiyama, Takaaki Nakamura & Yasuhiko Masuho. (2005) ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. FEBS Letters 579:30, pages 6796-6802.
Crossref
Jurgen A.F. MarteijnLiesbeth van EmstClaudia A.J. Erpelinck-VerschuerenGorica NikoloskiAswin MenkeTheo de WitteBob LöwenbergJoop H. JansenBert A. van der Reijden. (2005) The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells. Blood 106:13, pages 4114-4123.
Crossref
Kai He, Kimberly Loesch, Jon W. Cowan, Xin Li, Luqin Deng, Xiangdong Wang, Jing Jiang & Stuart J. Frank. (2005) Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor. Endocrinology 146:11, pages 4755-4765.
Crossref
Natalia A. Osna, Dahn L. Clemens & Terrence M. DonohueJr.Jr.. (2005) Ethanol metabolism alters interferon gamma signaling in recombinant HepG2 cells. Hepatology 42:5, pages 1109-1117.
Crossref
Daniela UngureanuOlli Silvennoinen. (2005) SLIM Trims STATs: Ubiquitin E3 Ligases Provide Insights for Specificity in the Regulation of Cytokine Signaling. Science's STKE 2005:304.
Crossref
Ulrike Sommer, Christine Schmid, Radoslaw M. Sobota, Ute Lehmann, Nigel J. Stevenson, James A. Johnston, Fred Schaper, Peter C. Heinrich & Serge Haan. (2005) Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation. Journal of Biological Chemistry 280:36, pages 31478-31488.
Crossref
Joel Raingeaud & Josiane Pierre. (2005) Interleukin-4 downregulates TNFα-induced IL-8 production in keratinocytes. FEBS Letters 579:18, pages 3953-3959.
Crossref
Wei TongJing ZhangHarvey F. Lodish. (2005) Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 105:12, pages 4604-4612.
Crossref
Thomas Clahsen, Ute Lehmann, Claudia Stross, Heike M. Hermanns, Rudolf Volkmer-Engert, Jens Schneider-Mergener, Peter C. Heinrich & Fred Schaper. (2005) The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling. Cellular Signalling 17:5, pages 559-569.
Crossref
Terri D. Richmond, Manprit Chohan & Dwayne L. Barber. (2005) Turning cells red: signal transduction mediated by erythropoietin. Trends in Cell Biology 15:3, pages 146-155.
Crossref
Marko Pesu, Fabio Candotti, Matthew Husa, Sigrun R. Hofmann, Luigi D. Notarangelo & John J. O'Shea. (2005) Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs. Immunological Reviews 203:1, pages 127-142.
Crossref
Edith Kario, Mina D. Marmor, Konstantin Adamsky, Ami Citri, Ido Amit, Ninette Amariglio, Gideon Rechavi & Yosef Yarden. (2005) Suppressors of Cytokine Signaling 4 and 5 Regulate Epidermal Growth Factor Receptor Signaling. Journal of Biological Chemistry 280:8, pages 7038-7048.
Crossref
Elizabeth J. Videlock, Victor K. Chung, Justin M. Hall, John Hines, Christina M. Agapakis & David J. Austin. (2005) Identification of a Molecular Recognition Role for the Activation Loop Phosphotyrosine of the Src Tyrosine Kinase. Journal of the American Chemical Society 127:6, pages 1600-1601.
Crossref
Yulan Qing, Ana P. Costa-Pereira, Diane Watling & George R. Stark. (2005) Role of Tyrosine 441 of Interferon-γ Receptor Subunit 1 in SOCS-1-mediated Attenuation of STAT1 Activation. Journal of Biological Chemistry 280:3, pages 1849-1853.
Crossref
Justin Mostecki, Brian M. Showalter & Paul B. Rothman. (2005) Early Growth Response-1 Regulates Lipopolysaccharide-induced Suppressor of Cytokine Signaling-1 Transcription. Journal of Biological Chemistry 280:4, pages 2596-2605.
Crossref
Beverly S. Chilton & Aveline Hewetson. 2005. 1 23 .
Subburaj Ilangumaran, Sheela Ramanathan & Robert Rottapel. (2004) Regulation of the immune system by SOCS family adaptor proteins. Seminars in Immunology 16:6, pages 351-365.
Crossref
Kirsi Paukku & Olli Silvennoinen. (2004) STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine & Growth Factor Reviews 15:6, pages 435-455.
Crossref
Tadashi Matsuda, Jian Feng, Bruce A. Witthuhn, Yuichi Sekine & James N. Ihle. (2004) Determination of the transphosphorylation sites of Jak2 kinase. Biochemical and Biophysical Research Communications 325:2, pages 586-594.
Crossref
Melissa G. Hunter, Anand Jacob, Lynn C. O’Donnell, Amanda Agler, Lawrence J. Druhan, K. Mark Coggeshall & Belinda R. Avalos. (2004) Loss of SHIP and CIS Recruitment to the Granulocyte Colony-Stimulating Factor Receptor Contribute to Hyperproliferative Responses in Severe Congenital Neutropenia/Acute Myelogenous Leukemia. The Journal of Immunology 173:8, pages 5036-5045.
Crossref
Betsy J. Barnes, John Richards, Margo Mancl, Sam Hanash, Laura Beretta & Paula M. Pitha. (2004) Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection. Journal of Biological Chemistry 279:43, pages 45194-45207.
Crossref
John C. Sitko, Claudia I. Guevara & Nicholas A. Cacalano. (2004) Tyrosine-phosphorylated SOCS3 Interacts with the Nck and Crk-L Adapter Proteins and Regulates Nck Activation. Journal of Biological Chemistry 279:36, pages 37662-37669.
Crossref
Warren S. AlexanderDouglas J. Hilton. (2004) T he R ole of S uppressors of C ytokine S ignaling (SOCS) P roteins in R egulation of the I mmune R esponse . Annual Review of Immunology 22:1, pages 503-529.
Crossref
Julie Bayle, Sébastien Letard, Ronald Frank, Patrice Dubreuil & Paulo De Sepulveda. (2004) Suppressor of Cytokine Signaling 6 Associates with KIT and Regulates KIT Receptor Signaling. Journal of Biological Chemistry 279:13, pages 12249-12259.
Crossref
Elizabeth Rico-Bautista, Ciro Negrı́n-Martı́nez, Javier Novoa-Mogollón, Leandro Fernández-Perez & Amilcar Flores-Morales. (2004) Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. Experimental Cell Research 294:1, pages 269-280.
Crossref
Samuel Wormald & Douglas J. Hilton. (2004) Inhibitors of Cytokine Signal Transduction. Journal of Biological Chemistry 279:2, pages 821-824.
Crossref
R Plaza, S Vidal, J.L Rodriguez-Sanchez & C Juarez. (2004) Implication of STAT1 and STAT3 transcription factors in the response to superantigens. Cytokine 25:1, pages 1-10.
Crossref
T. Hanada, I. Kinjyo, K. Inagaki-Ohara & A. Yoshimura. 2004. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology 72 86 .
G. J. Strous, C. Alves dos Santos, J. Gent, R. Govers, M. Sachse, J. Schantl & P. van Kerkhof. 2004. Signalling from Internalized Growth Factor Receptors. Signalling from Internalized Growth Factor Receptors 81 118 .
Simona PoloStefano ConfalonieriAnna Elisabetta SalciniPier Paolo Di Fiore. (2003) EH and UIM: Endocytosis and More. Science's STKE 2003:213.
Crossref
Samir Ali, Zaynab Nouhi, Naila Chughtai & Suhad Ali. (2003) SHP-2 Regulates SOCS-1-mediated Janus Kinase-2 Ubiquitination/Degradation Downstream of the Prolactin Receptor. Journal of Biological Chemistry 278:52, pages 52021-52031.
Crossref
Minoru Fujimoto & Tetsuji Naka. (2003) Regulation of cytokine signaling by SOCS family molecules. Trends in Immunology 24:12, pages 659-666.
Crossref
Akihide Ryo, Futoshi Suizu, Yasuhiro Yoshida, Kilian Perrem, Yih-Cherng Liou, Gerburg Wulf, Robert Rottapel, Shoji Yamaoka & Kun Ping Lu. (2003) Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA. Molecular Cell 12:6, pages 1413-1426.
Crossref
Ke Shuai & Bin Liu. (2003) Regulation of JAK–STAT signalling in the immune system. Nature Reviews Immunology 3:11, pages 900-911.
Crossref
Subburaj Ilangumaran, Dina Finan, Jason Raine & Robert Rottapel. (2003) Suppressor of Cytokine Signaling 1 Regulates an Endogenous Inhibitor of a Mast Cell Protease. Journal of Biological Chemistry 278:43, pages 41871-41880.
Crossref
Subburaj Ilangumaran, Sheela Ramanathan, Jose La Rose, Philippe Poussier & Robert Rottapel. (2003) Suppressor of Cytokine Signaling 1 Regulates IL-15 Receptor Signaling in CD8+CD44high Memory T Lymphocytes. The Journal of Immunology 171:5, pages 2435-2445.
Crossref
Shu Okugawa, Yasuo Ota, Takatoshi Kitazawa, Kuniko Nakayama, Shintaro Yanagimoto, Kunihisa Tsukada, Miki Kawada & Satoshi Kimura. (2003) Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages. American Journal of Physiology-Cell Physiology 285:2, pages C399-C408.
Crossref
Ana Elorza, Petronila Penela, Susana Sarnago & Federico MayorJr.Jr.. (2003) MAPK-dependent Degradation of G Protein-coupled Receptor Kinase 2. Journal of Biological Chemistry 278:31, pages 29164-29173.
Crossref
Serge Haan, Paul Ferguson, Ulrike Sommer, Meena Hiremath, Daniel W. McVicar, Peter C. Heinrich, James A. Johnston & Nicholas A. Cacalano. (2003) Tyrosine Phosphorylation Disrupts Elongin Interaction and Accelerates SOCS3 Degradation. Journal of Biological Chemistry 278:34, pages 31972-31979.
Crossref
Ann D. Friedman, Dipali Nimbalkar & Frederick W. Quelle. (2003) Erythropoietin Receptors Associate with a Ubiquitin Ligase, p33RUL, and Require Its Activity for Erythropoietin-induced Proliferation. Journal of Biological Chemistry 278:29, pages 26851-26861.
Crossref
Martin Aringer, Sigrun R. Hofmann, David M. Frucht, Min Chen, Michael Centola, Akio Morinobu, Roberta Visconti, Daniel L. Kastner, Josef S. Smolen & John J. O’Shea. (2003) Characterization and Analysis of the Proximal Janus Kinase 3 Promoter . The Journal of Immunology 170:12, pages 6057-6064.
Crossref
Pipsa SaharinenMauno Vihinen & Olli Silvennoinen. (2003) Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase Domain. Molecular Biology of the Cell 14:4, pages 1448-1459.
Crossref
Subburaj Ilangumaran & Robert Rottapel. (2003) Regulation of cytokine receptor signaling by SOCS1. Immunological Reviews 192:1, pages 196-211.
Crossref
Fabrizio Giordanetto & Romano T. Kroemer. (2003) A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1). Protein Engineering, Design and Selection 16:2, pages 115-124.
Crossref
Manjula Bhanoori, Chandrahasa R Yellaturu, Salil K Ghosh, Aviv Hassid, Lisa K Jennings & Gadiparthi N Rao. (2003) Thiol alkylation inhibits the mitogenic effects of platelet-derived growth factor and renders it proapoptotic via activation of STATs and p53 and induction of expression of caspase1 and p21waf1/cip1. Oncogene 22:1, pages 117-130.
Crossref
Joanne L. Eyles & Douglas J. Hilton. 2003. Handbook of Cell Signaling. Handbook of Cell Signaling 431 440 .
Akihiko Yoshimura, Ichiko Kinjyo, Kyoko Inagaki-Ohara & Toshikatsu Hanada. 2003. Signal Transducers and Activators of Transcription (STATs). Signal Transducers and Activators of Transcription (STATs) 545 558 .
Pipsa Saharinen & Olli Silvennoinen. 2003. Signal Transducers and Activators of Transcription (STATs). Signal Transducers and Activators of Transcription (STATs) 27 42 .
Pipsa Saharinen & Olli Silvennoinen. (2002) The Pseudokinase Domain Is Required for Suppression of Basal Activity of Jak2 and Jak3 Tyrosine Kinases and for Cytokine-inducible Activation of Signal Transduction. Journal of Biological Chemistry 277:49, pages 47954-47963.
Crossref
Ling Xia, Lijuan Wang, Alicia S. Chung, Stanimir S. Ivanov, Mike Y. Ling, Ana M. Dragoi, Adam Platt, Tona M. Gilmer, Xin-Yuan Fu & Y. Eugene Chin. (2002) Identification of Both Positive and Negative Domains within the Epidermal Growth Factor Receptor COOH-terminal Region for Signal Transducer and Activator of Transcription (STAT) Activation. Journal of Biological Chemistry 277:34, pages 30716-30723.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.